BLOOD clots should be listed as a "very rare" side effect of the Johnson & Johnson coronavirus vaccine but its benefits still outweigh the risks, the EU's drug watchdog said on Tuesday.
The European Medicines Agency (EMA) said in a statement that it had found a "possible link" between the jab and the clots, following eight such cases in the United States, one of which was fatal.
Concerns over the vaccine by US pharmaceutical giant Johnson & Johnson and the jab by rival drugmaker AstraZeneca have dampened hopes that vaccines could offer a swift end to the pandemic.
"EMA finds possible link to very rare cases of unusual blood clots with low blood platelets," the Amsterdam-based agency said in a statement, adding that it "confirms (the) overall benefit-risk remains positive."
The regulator said its safety committee "concluded that a warning about unusual blood clots with low blood platelets should be added to the product information" for the J&J shot.
Its experts also "concluded that these events should be listed as very rare side effects of the vaccine."
"The cases reviewed were very similar to the cases that occurred with the Covid-19 vaccine developed by AstraZeneca, Vaxzevria," the EMA statement said.
The eight cases in the US, out of some seven million people who had received the vaccine, all involved people under the age of 60, the majority of whom were women, it said.
"Based on the currently available evidence, specific risk factors have not been confirmed," the EMA said.
EMA chief Emer Cooke was due to hold a press conference on the decision at 1500 GMT.
- Adenovirus technology -
Johnson & Johnson last week delayed the rollout of its single-shot jab across Europe pending the result of the EMA probe.
J&J said earlier Tuesday that it was "very confident" in its vaccine and hopeful for a quick resolution from regulators over its status.
The EU approved the Johnson & Johnson shot on March 11 and started taking delivery of the vaccine on April 19.
But with concerns already mounting over clots linked to AstraZeneca, the EMA announced on April 9 that it was also probing cases connected to the J&J vaccine.
US regulators have suspended the Johnson & Johnson vaccine and is set to announce its decision on Friday.
Both the Johnson & Johnson and AstraZeneca vaccines use the same adenovirus vector technology.
They use a common-cold causing adenovirus, modified so it cannot replicate, as a "vector" to shuttle genetic instructions into human cells, telling them to create a protein of the coronavirus, and training them to be ready for live Covid.
AstraZeneca opted for a chimpanzee adenovirus, J&J for a human adenovirus.
Other Covid adenovirus vector vaccines include Russia's Sputnik V and China's CanSino.
Many European countries have continued to restrict the use of AstraZeneca, despite the EMA declaring it safe and saying blood clots are only a "very rare" side effect.
ETX Studio
Wed Apr 21 2021
![EMA links Johnson & Johnson vaccine to blood clots EMA links Johnson & Johnson vaccine to blood clots](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-01/51611979307_JohnsonJohnson.jpg)
Concerns over the vaccine by US pharmaceutical giant Johnson & Johnson and the jab by rival drugmaker AstraZeneca have dampened hopes that vaccines could offer a swift end to the pandemic. REUTERSpic
Kylian Mbappe tandatangan kontrak dengan Real Madrid
Bintang bola sepak Perancis Kylian Mbappe menandatangani kontrak selama lima tahun dengan kelab Sepanyol Real Madrid pada Selasa.
Pelepasan ketujuh air sisa nuklear Fukushima ke laut selesai
Jepun telah menyelesaikan pusingan ketujuh pelepasan air sisa radioaktif yang dirawat dari loji kuasa nuklear Fukushima Daiichi ke Lautan Pasifik pada Selasa.
Empat termasuk kapten maut dalam pertempuran
Empat anggota tentera India termasuk kapten meninggal dunia akibat kecederaan selepas pertempuuran pada malam isnin di Hutan Desa.
Pakistan sahkan 4 warganya terbunuh di Oman
Pakistan berkata pada Selasa empat warganya terbunuh dalam insiden tembakan pada malam Isnin berhampiran ibu negara Oman, Muscat.
Lima terbunuh, puluhan cedera dalam protes antikuota di Bangladesh
Sekurang-kurangnya empat orang terbunuh dan puluhan lagi cedera dalam pertempuran antara pelajar yang memprotes sistem kuota dalam pekerjaan sektor awam dan polis di pelbagai bahagian Bangladesh pada Selasa.
Kerajaan cadang perkenal pembiayaan swasta
Kerajaan menyasarkan untuk memperkenalkan pembiayaan swasta alternatif bagi memastikan kemampanan kewangan program sektor air, sekali gus mengurangkan kebergantungan pada perbelanjaan kerajaan dan mengukuhkan daya tahan.
Saya tak fitnah Guan Eng, cuma jelaskan siasatan SPRM - Muhyiddin
Presiden Bersatu Tan Sri Muhyiddin Yassin memberitahu Mahkamah Tinggi Kuala Lumpur hari ini bahawa beliau tidak memfitnah Lim Guan Eng berhubung isu pengecualian cukai terhadap Yayasan Albukhary
KPT alu-alukan dapatan, cadangan PAC - Zambry
Ini termasuklah cadangan pelaksanaan Garis Panduan Pelaburan dan Pembiayaan oleh Universiti Awam 2024 kepada anak-anak syarikat di bawah seliaan Kementerian Pendidikan Tinggi (KPT).
Lebih 340,000 syarikat buat transaksi serah simpan maklumat pemunyaan benefisial
Sebanyak 340,637 syarikat telah membuat transaksi serah simpan maklumat pemunyaan benefisial (beneficial ownership) bagi tempoh 1 April hingga 14 Julai lepas.
Polis tunggu laporan makmal tentukan punca kematian Nur Farah Kartini
Polis sedang menunggu laporan makmal bagi menentukan punca kematian berhubung kes pembunuhan bekas penuntut Universiti Pendidikan Sultan Idris, Nur Farah Kartini Abdullah.
![Vaksin COVID-19: Malaysia lulus penggunaan kecemasan Sinopharm, Johnson & Johnson Vaksin COVID-19: Malaysia lulus penggunaan kecemasan Sinopharm, Johnson & Johnson](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-07/81626409203_SinopharmdanJohnso.jpg)
Vaksin COVID-19: Malaysia lulus penggunaan kecemasan Sinopharm, Johnson & Johnson
Kelulusan pendaftaran bersyarat ini memerlukan maklumat kualiti, keselamatan dan keberkesanan produk vaksin tersebut dipantau dan dinilai.
![COVID-19: Pakar optimis trend kematian di AS tidak seteruk tahun lalu COVID-19: Pakar optimis trend kematian di AS tidak seteruk tahun lalu](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-06/61623106811_NEWYORKVACCINE.jpg)
COVID-19: Pakar optimis trend kematian di AS tidak seteruk tahun lalu
Profesor epidemiologi di Johns Hopkins University, Dr David Dowdy optimis kadar kematian tidak akan menyamai trend tahun lalu.
![Vaksin COVID-19: Johnson & Johnson berkesan tangani varian Delta Vaksin COVID-19: Johnson & Johnson berkesan tangani varian Delta](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-07/51625193667_JohnsonJohnson.jpg)
Vaksin COVID-19: Johnson & Johnson berkesan tangani varian Delta
Data menunjukkan ketahanan tindak balas imunisasi bagi penerima vaksinnya bertahan sekurang-kurangnya lapan bulan.
![COVID-19: Suntikan ketiga vaksin AstraZeneca tingkatkan tindak balas imun COVID-19: Suntikan ketiga vaksin AstraZeneca tingkatkan tindak balas imun](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-06/71624898589_AstraZenecaCOVID.jpg)
COVID-19: Suntikan ketiga vaksin AstraZeneca tingkatkan tindak balas imun
Suntikan ketiga vaksin AstraZeneca hasilkan tindak balas imun yang kuat
![Penduduk Pulau Perhentian, Redang dijangka terima suntikan vaksin satu dos Penduduk Pulau Perhentian, Redang dijangka terima suntikan vaksin satu dos](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-06/51622553024_PengerusiJawatankua.jpg)
Penduduk Pulau Perhentian, Redang dijangka terima suntikan vaksin satu dos
Vaksin satu dos dilihat lebih bertepatan untuk disuntik kepada penduduk yang tinggal di kawasan tersebut.
![Berita antarabangsa pilihan sepanjang hari ini Berita antarabangsa pilihan sepanjang hari ini](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-04/51617709639_BAP.jpg)
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
![Mexico terima 1.35 juta dos vaksin Johnson & Johnson dari AS Mexico terima 1.35 juta dos vaksin Johnson & Johnson dari AS](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-04/61618350694_TBMEXICOVACCINE.jpg)
Mexico terima 1.35 juta dos vaksin Johnson & Johnson dari AS
Selepas selesai menerima suntikan vaksin, sekatan sempadan tidak akan diteruskan.
![Sarawak sudah mohon peruntukan CanSino daripada Kerajaan Pusat Sarawak sudah mohon peruntukan CanSino daripada Kerajaan Pusat](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-05/41622453183_Vaksinator.jpg)
Sarawak sudah mohon peruntukan CanSino daripada Kerajaan Pusat
Sarawak telah menghantar permohonan kepada Kerajaan Pusat peruntukan menerima vaksin CanSino untuk kegunaan negeri itu.
![Penggunaan CanSino dan Johnson & Johnson bantu percepatkan imuniti kelompok Penggunaan CanSino dan Johnson & Johnson bantu percepatkan imuniti kelompok](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-06/71623239561_Vaccine.jpg)
Penggunaan CanSino dan Johnson & Johnson bantu percepatkan imuniti kelompok
Penggunaan dua jenis vaksin buatan CanSino dan Johnson & Johnson (J&J) dilihat mampu mempercepatkan sasaran pemberian vaksin terhadap seluruh masyarakat.
![Vaksin CanSino, Johnson & Johnson diluluskan untuk pendaftaran bersyarat Vaksin CanSino, Johnson & Johnson diluluskan untuk pendaftaran bersyarat](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-06/71623741676_JohnsonCanSino.jpg)
Vaksin CanSino, Johnson & Johnson diluluskan untuk pendaftaran bersyarat
Kedua-dua vaksin itu hanya memerlukan satu dos.